Literature DB >> 25017644

Effects of MDMA on olfactory memory and reversal learning in rats.

Andrew Hawkey1, L Brooke April1, Mark Galizio2.   

Abstract

The effects of acute and sub-chronic MDMA were assessed using a procedure designed to test rodent working memory capacity: the odor span task (OST). Rats were trained to select an odor that they had not previously encountered within the current session, and the number of odors to remember was incremented up to 24 during the course of each session. In order to separate drug effects on the OST from more general performance impairment, a simple olfactory discrimination was also assessed in each session. In Experiment 1, acute doses of MDMA were administered prior to select sessions. MDMA impaired memory span in a dose-dependent fashion, but impairment was seen only at doses (1.8 and 3.0 mg/kg) that also increased response omissions on both the simple discrimination and the OST. In Experiment 2, a sub-chronic regimen of MDMA (10.0 mg/kg, twice daily over four days) was administered after OST training. There was no evidence of reduced memory span following sub-chronic MDMA, but a temporary increase in omission errors on the OST was observed. In addition, rats exposed to sub-chronic MDMA showed delayed learning when the simple discrimination was reversed. Overall, the disruptive effects of both acute and sub-chronic MDMA appeared to be due to non-mnemonic processes, rather than effects on specific memory functions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MDMA; Odor span; Olfaction; Reversal learning; Working memory

Mesh:

Substances:

Year:  2014        PMID: 25017644      PMCID: PMC4143477          DOI: 10.1016/j.nlm.2014.06.012

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  39 in total

1.  The relative contributions of ecstasy and cannabis to cognitive impairment.

Authors:  R J Croft; A J Mackay; A T Mills; J G Gruzelier
Journal:  Psychopharmacology (Berl)       Date:  2001-01       Impact factor: 4.530

Review 2.  Animal models of working memory: a review of tasks that might be used in screening drug treatments for the memory impairments found in schizophrenia.

Authors:  Paul A Dudchenko; John Talpos; Jared Young; Mark G Baxter
Journal:  Neurosci Biobehav Rev       Date:  2012-03-22       Impact factor: 8.989

Review 3.  An overview of the tasks used to test working memory in rodents.

Authors:  Paul A Dudchenko
Journal:  Neurosci Biobehav Rev       Date:  2004-11       Impact factor: 8.989

4.  3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory.

Authors:  Jessica A Able; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Biol Psychiatry       Date:  2005-12-01       Impact factor: 13.382

5.  Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.

Authors:  W Slikker; R R Holson; S F Ali; M G Kolta; M G Paule; A C Scallet; D E McMillan; J R Bailey; J S Hong; F M Scalzo
Journal:  Neurotoxicology       Date:  1989       Impact factor: 4.294

6.  Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.

Authors:  L J Spanos; B K Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  1989-04       Impact factor: 3.533

7.  Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats.

Authors:  June M Young; Iain S McGregor; Paul E Mallet
Journal:  Neuropsychopharmacology       Date:  2005-08       Impact factor: 7.853

8.  Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.

Authors:  S de Sola Llopis; M Miguelez-Pan; J Peña-Casanova; S Poudevida; M Farré; R Pacifici; P Böhm; S Abanades; A Verdejo García; K Langohr; P Zuccaro; R de la Torre
Journal:  J Psychopharmacol       Date:  2008-01-21       Impact factor: 4.153

9.  MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning.

Authors:  Jacobi I Cunningham; Jamie Raudensky; John Tonkiss; Bryan K Yamamoto
Journal:  Behav Neurosci       Date:  2009-10       Impact factor: 1.912

10.  MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

Authors:  G Battaglia; S Y Yeh; E B De Souza
Journal:  Pharmacol Biochem Behav       Date:  1988-02       Impact factor: 3.533

View more
  6 in total

1.  Behavioral pharmacology of the odor span task: Effects of flunitrazepam, ketamine, methamphetamine and methylphenidate.

Authors:  Mark Galizio; Brooke April; Melissa Deal; Andrew Hawkey; Danielle Panoz-Brown; Ashley Prichard; Katherine Bruce
Journal:  J Exp Anal Behav       Date:  2016-10-17       Impact factor: 2.468

2.  Olfactory Stimulus Control and the Behavioral Pharmacology of Remembering.

Authors:  Mark Galizio
Journal:  Behav Anal (Wash D C)       Date:  2016-03-17

3.  Effects of NMDA antagonist dizocilpine (MK-801) are modulated by the number of distractor stimuli in the rodent odor span task of working memory.

Authors:  Mark Galizio; Melissa Deal; Michael Mathews; Danielle Panoz-Brown; Ashley Prichard; Katherine E Bruce
Journal:  Neurobiol Learn Mem       Date:  2019-03-09       Impact factor: 2.877

4.  Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose.

Authors:  Madeline M Pantoni; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

5.  A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

Authors:  Devahuti Chaliha; John C Mamo; Matthew Albrecht; Virginie Lam; Ryu Takechi; Mauro Vaccarezza
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

6.  Influence of pharmacological manipulations of NMDA and cholinergic receptors on working versus reference memory in a dual component odor span task.

Authors:  David A MacQueen; Savannah R Dalrymple; David J Drobes; David M Diamond
Journal:  Learn Mem       Date:  2016-05-18       Impact factor: 2.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.